KOSPI · Healthcare · ₩179B
₩7,9700.00%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
9/'26
6/'26 vs prev quarter
Short Volume 4.3% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“이번 분기, 생산 기반이 매출로 이어지는지 봐요.”
In the company's words · 2026 2분기 filing